Normal View Dyslexic View

Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).

Xie D, Shen J, Liu L, Cao B, Xiao A, Qin J et al.

Br J Surg 2024; 111: znae106.

In this study that included 169 patients, the addition of complete mesogastric excision improved 3-year disease-free survival (85 versus 75.5 per cent, P=0.042), but not quite overall survival (85.8 versus 77.5 per cent, P=0.058).

Comment: It remains unknown whether this makes a big enough difference.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK

Related articles


Copied!